Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: SICAV
  • Objective: European Region
  • Asset Class: Equity
  • Geographic Focus: European Region

T Rowe Price Funds SICAV - European Structured Research Equity Fund

+ Add to Watchlist

TRPESRI:LX

21.23 EUR 0.08 0.38%

As of 00:59:30 ET on 05/22/2015.

Snapshot for T Rowe Price Funds SICAV - European Structured Research Equity Fund (TRPESRI)

Year To Date: +22.01% 3-Month: +9.32% 3-Year: +20.12% 52-Week Range: 15.75 - 21.23
1-Month: +1.34% 1-Year: +22.29% 5-Year: +14.36% Beta vs MXEU: 0.94

Mutual Fund Chart for TRPESRI

No chart data available.
  • TRPESRI:LX 21.23
  • 1M
  • 1Y
Interactive TRPESRI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for TRPESRI

T Rowe Price Funds SICAV- European Structured Research Equity Fund is an open-end Fund incorporated in Luxembourg. The Fund's objective is to provide long-term capital appreciation through investment in primarily transferable securities and Equity related securities.

Inception Date: 01-07-2005 Telephone: 352-27-47-251 Tel
Managers: ANN M HOLCOMB / MITCHELL TODD
Web Site: www.troweprice.com/institutional

Fundamentals for TRPESRI

NAV (on 2015-05-22) 21.23
Assets (M) (on 2015-05-22) 7.96
Fund Leveraged N
Minimum Investment 2,500,000.00
Minimum Subsequent Investment 100,000.00

Dividends for TRPESRI

No dividends reported

Fees & Expenses for TRPESRI

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.55
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 0.65

Top Fund Holdings for TRPESRI

Filing Date: 03/31/2015
Name Position Value % of Total
Nestle SA 3,202 224,838 2.960%
Novartis AG 2,330 214,728 2.827%
Roche Holding AG 703 180,651 2.378%
Royal Dutch Shell PLC 6,252 172,990 2.277%
Novo Nordisk A/S 2,436 122,425 1.612%
HSBC Holdings PLC 14,543 115,283 1.518%
Vodafone Group PLC 37,229 113,392 1.493%
GlaxoSmithKline PLC 5,157 110,276 1.452%
Barclays PLC 30,936 103,511 1.363%
BNP Paribas SA 1,783 100,722 1.326%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil